Increased autoantibody prevalence has been described in instances of high-dose exposure to polychlorinated biphenyls (PCBs). In 1996, an equipment malfunction at the Swan Hills Treatment Centre in Alberta, Canada, caused the release of gases containing PCBs into the ambient air. In view of the immune effects of PCBs and their potential as endocrine disruptors, we assessed autoantibody prevalence and looked for correlations with PCB levels.
Methods
Fifty-seven persons living within a 100 km radius of the waste treatment facility were assessed. Autoantibodies were measured by indirect immunofluorescence, double immunodiffusion, and immunoblotting. The levels of 26 congeners of PCBs were measured by gas chromatography and mass spectrometry. Provincial health records for physician visits and hospitalizations were reviewed for diagnoses of autoimmune disease.
Results
The prevalence of autoantibodies was 11% in the study participants and 0% in healthy controls. There was no correlation of PCB levels with autoantibody results. There was no associated increase in autoimmune disease noted on physician visits or hospitalizations. PCB levels were comparable to background levels reported for other populations.
Conclusion
A correlation of titers of autoantibodies in the sera of individuals at risk and the blood levels of PCBs was not found, and the prevalence of autoantibodies in the at-risk group was not statistically different (p > .05) from that of an unexposed control group. The study group had higher titers of autoantibodies and some strong reactivity with intracellular antigens, but the significance of this observation may be understood only after long-term clinical assessments and follow-up.
Agency for Toxic Substances and Disease Registry.Toxicological profile for polychlorinated biphenyls (PCBs).Atlanta (GA): US Department of Health and Human Services, Public Health Service; 2000. No. 1–1.
2.
Weisglas-KuperusN.Neurodevelopmental, immunological and endocrinological indices of perinatal human exposure to PCBs and dioxins.Chemosphere1998; 37: 1845–53.
3.
NakanishiY., ShigematsuN., KuritaY.Respiratory involvement and immune status in yusho patients.Environ Health Perspect1985; 59: 31–6.
4.
LuY.C., WuY.C.Clinical findings and immunological abnormalities in Yu-Cheng patients.Environ Health Perspect1985; 59: 17–29.
5.
Van Den HeuvelR.L., KoppenG., StaessenJ.A.Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium).Environ Health Perspect2002; 110: 595–600.
6.
SvenssonB.G., HallbergT., NilssonA.Parameters of immunological competence in subjects with high consumption of fish contaminated with persistent organochlorine compounds.Int Arch Occup Environ Health1994; 65: 351–8.
7.
KimbroughR.D., KrouskasC.A.Polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans and birth weight and immune and thyroid function in children.Regul Toxicol Pharmacol2001; 34: 42–52.
8.
FernlofG., GadhassonI., PodraK.Lack of effects of some individual polybrominated diphenyl ether (PBDE) and polychlorinated biphenyl (PCB) congeners on human lymphocyte functions in vitro.Toxicol Lett1997; 90: 189–97.
9.
Weisglas-KuperusN., PatandinS., BerbersG.Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children.Environ Health Perspect2000; 108: 1203–7.
10.
DewaillyE., AyotteP., BruneauS.Susceptibility to infections and immune status in Inuit infants exposed to organochlorines.Environ Health Perspect2000; 108: 205–11.
11.
TryphonasH.Immunotoxicity of PCBs (Aroclors) in relation to Great Lakes.Environ Health Perspect1995; 103 Suppl 9: 35–46.
12.
BigazziP.E.Autoimmunity and heavy metals.Lupus1994; 3: 449–53.
13.
PowellJ.J., Van de WaterJ., GershwinM.E.Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions.Environ Health Perspect1999; 107 Suppl 5: 667–72.
14.
NietertP.J., SutherlandS.E., SilverR.M.Is occupational organic solvent exposure a risk factor for scleroderma?Arthritis Rheum1998; 41: 1111–8.
15.
TanE.M., CohenA.S., FriesJ.F.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1982; 25: 1271–7.
16.
ArnettF.C., EdworthyS.M., BlochD.A.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988; 31: 315–24.
17.
TanE.M., RodnanG.P., GarciaI.Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.Arthritis Rheum1980; 23: 617–25.
18.
SteenV.D., PowellD.L., MedsgerT.A.Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.Arthritis Rheum1988; 31: 196–203.
19.
TsujiH., HirahashiT., OgataH., FujishimaM.[Serum immunoglobulin concentrations and autoantibodies in patients with Yusho].Fukuoka Igaku Zasshi1999; 90: 147–9.
20.
TsujiH.[Immune effects of endocrine disruptors].Nippon Rinsho2000; 58: 2533–8.
21.
YuM.L., HsinJ.W., HsuC.C.The immunologic evaluation of the Yucheng children.Chemosphere1998; 37: 1855–65.
22.
DanielV., HuberW., BauerK.Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies.Environ Health Perspect2001; 109: 173–8.
23.
LangerP., TajtakovaM., GuretzkiH-JHigh prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in employees at a polychlorinated biphenyl production factory.Arch Environ Health2002; 57: 412–5.
24.
VreugdenhilH.J.I., SlijperF.M.E., MulderP.G.H., Weisglas-KuperusN.Effects of perinatal exposure to PCBs and dioxins on play behavior in Dutch children at school age.Environ Health Perspect2002; 110: A593–8.
25.
AokiY.Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, and polychlorinated dibenzofurans as endocrine disrupters—what we have learned from Yusho disease.Environ Res2001; 86: 2–11.
26.
BergeronJ.M., CrewsD., McLachlanJ.A.PCBs as environmental estrogens: turtle sex determination as a biomarker of environmental contamination.Environ Health Perspect1994; 102: 780–1.
27.
VosJ.G., DybingE., GreimH.A.Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation.Crit Rev Toxicol2000; 30: 71–133.
28.
CutoloM., WilderR.Neuroendocrine mechanisms in rheumatic diseases. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases.Rheum Dis Clin North Am2000; 26: 825–39.
PetriM., HowardD., RepkeJ.Frequency of lupus flare in pregnancy The Hopkins Lupus Pregnancy Center experience.Arthritis Rheum1991; 34: 1538–45.
31.
Alberta government seeks buyer for Swan Hills Treatment Centre. Available at: http://www.gov.ab.ca/acn/200105/10704.html. Government of Alberta (accessed May 18, 2001).
32.
Health Surveillance, Alberta Health and Wellness.Swan Hills Special Waste Treatment Center human health impact assessment.Edmonton (AB): Government of Alberta, Canada; 1997.
33.
World Health Organization.International classification of diseases, ninth revision: basic tabulation list with alpha-betical index.4th ed.Geneva: World Health Organization; 1978.
34.
Van den BergM., BirnbaumL., BosveldA.T.C.Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs, for humans and wildlife.Environ Health Perspect1998; 106: 775–92.
35.
TanE.M., FeltkampT.E.W., SmolenJ.S.Range of antinuclear antibodies in “healthy” individuals.Arthritis Rheum1997; 40: 1601–11.
36.
LaemmliU.K.Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970; 227: 680–5.
37.
SmolenJ.S., ButcherB., FritzlerM.J.Reference sera for antinuclear antibodies.Arthritis Rheum1997; 40: 413–8.
38.
WeiselC., YuR., RoyA., GeorgopoulosP.Biomarkers of environmental benzene exposure.Environ Health Perspect1996; 104: 1141–6.
39.
ArnettF.C., FritzlerM.J., AnnC., HolianA.Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin).J Rheumatol2000; 27: 405–10.
40.
MelnickR., LucierG., WolfeM.Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review.Environ Health Perspect2002; 110: 427–31.
41.
HeudorfU., AngererJ., DrexlerH.Polychlorinated biphenyls in the blood plasma: current exposure of the population in Germany.Rev Environ Health2002; 17: 123–34.
42.
BeckerK., KausS., KrauseC.German Environmental Survey 1998 (GerES III): environmental pollutants in blood of the German population.Int J Hyg Environ Health2002; 205: 297–308.
43.
RyanJ.J., GilmanA.Contemporary Canadian exposure of the general population to dioxin-like and organochlorine compounds.Ottawa (ON): Food and Environmental Health Directorates, Health Protection Branch, Health Canada; 1997.
44.
DewaillyE., RyanJ.J., LaliberteC.Exposure of remote maritime populations to coplanar PCBs.Environ Health Perspect1994; 102 Suppl 1: 205–9.
45.
ColtonT.Inference on Proportions. In: Statistics in medicine.1st ed.Boston: Little, Brown and Company; 1974. p. 151–88.
46.
von MuhlenC.A., TanE.M.Autoantibodies in the diagnosis of systemic rheumatic diseases.Semin Arthritis Rheum1995; 24: 323–58.
47.
FritzlerM.J., PaulsJ.D., KinsellaT.D., BowenT.G.Antinuclear, anticytoplasmic and anti-Sjogren's syndrome antigen-A (SS-A/Ro) antibodies in female blood donors.Clin Immunol Immunopathol1985; 36: 120–8.
48.
JacobsonD.L., GangeS.J., RoseN.R., GrahamN.M.Epidemiology and estimated population burden of selected autoimmune diseases in the United States.Clin Immunol Immunopathol1997; 84: 223–43.
49.
ParksC., ConradK., CooperG.Occupational exposure to crystalline silica and autoimmune disease.Environ Health Perspect1999; 107: 793–802.
